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Abstract
Background: The first case of 2009 pandemic influenza A (H1N1) virus infection in our center was documented on
June 15. Subsequently, persons with suspected cases of infection and contacts of those with suspected infection
were tested. Persons in whom infection was confirmed were hospitalized and quarantined, and some of them
were closely observed for the purpose of investigating the nature and duration of the disease. The aim of the
present study was to describe baseline characteristics, treatment, outcomes, hospital length of stay and mortality of
the first 186 cases of influenza A (H1N1) virus infection, with special interest in those developing severe respiratory
failure with intensive care unit (ICU) care requirement.
Methods: observational study of 186 consecutive cases of influenza A (H1N1) virus infection admitted in 3
departments that were reference centers for the care of patients with influenza A and 4 ICU in Ibn Sina university
hospital (Rabat, Morocco) between June and December 2009. Real time reverse-transcriptase-polymerase-chain-
reaction (RT-PCR) testing was used to confirm infection. Demographic data, symptoms, comorbid conditions, illness
progression, laboratory and chest radiologic findings, treatments, clinical outcomes and ICU care requirement were
closely monitored.
Results: The mean age of the 186 patients was 17.6 ± 14.8 years, 47.8% had less than 14 years and 57% were
male. The median duration of symptoms before hospital admission was 3 days (interquartile range (IQR): 2-5). The
most common symptoms were fever (in 91.5% of the patients), cough in 92.5%, and nasal congestion in 62.4%.
Twenty four percent of patients had comorbid respiratory disorders and 7.5% were pregnant. Abnormalities in
chest radiography were detected in 26.3% of 186 patients on admission or after hospitalization. Twenty patients
have required ICU care and 10 have required mechanical ventilation. The hospital length of stay was 5 days (IQR:
4-5). The following were risk factors of ICU admission: older age (p = 0.03), long duration of symptoms (p = 0.07),
asthma (p = 0.01), obesity (P < 0.001), abnormalities of chest radiography (P < 0.001), leukocytosis (p = 0.005), and
higher C-reactive protein (CRP) (P < 0.001). The ICU length of stay was 4 days (IQR: 3-6.7). The mortality rate was
3.5% among all patients and 30% among ICU patients.
Conclusions: Close observation of patients infected with the 2009 pandemic influenza A (H1N1) virus infection
provided us with several information. The influenza A (H1N1) virus infection affected young people particularly,
with comorbid respiratory disorders. Risk factors of ICU admission were older age, long duration of symptoms,
asthma, obesity, abnormalities of chest radiography, leukocytosis and higher CRP. Clinicians should be aware of
complications of influenza A (H1N1) virus infection, particulary in patients with risk factors.
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In April 2009, cases of human infection with 2009 pan-
demic influenza A (H1N1) virus were identified in the
United States and Mexico [1,2] and then the virus spread
rapidly to other regions of the world [3,4]. Thus, the
world health organization (WHO) raised the pandemic
level from 5 to 6, the highest level [5]. The 2009 H1N1
virus is a triple resorting influenza virus containing genes
from human, swine and avion influenza viruses [6-8].
The transmission human to human of the virus was
documented [9]. Influenza pandemics of the past century
have been associated with a remarkably consistent epide-
miologic curve, with peaks in the spring, fall, and later
winter [10]. The first case of confirmed infection with the
virus in our center was documented on June 15, 2009.
Since this was a new and potentially serious infection dis-
ease, all patients with confirmed infection who had been
hospitalized were quarantined in the hospital to isolate
them from the general population. To our Knowledge,
there are no studies that investigated influenza A (H1N1)
virus infection in developing countries. Some patients
with influenza A (H1N1) virus infection have developed
rapidly progressive lower respiratory tract disease result-
ing in respiratory failure with attributed death. Morocco
has a total population of 31,285,174; gross national
income per capita is $ 3.860. The health budget corre-
sponds to 1.1 percent of gross domestic product and 5.5
percent of the central government budget. Morocco has
inadequate numbers of physicians (0.5 per 1,000 people)
and hospital beds (1.0 per 1,000 people) and poor access
to water (82% of the population) and sanitation (75% of
the population). The health care system includes 122
hospitals; 2,400 health centers; and 4 university clinics,
but they are poorly maintained with inadequate capacity
to meet the demand for medical care. Only 24,000 beds
are available for 6 million patients seeking care each year,
including 3 million emergency cases [11]. Morocco has
two major health sectors, public and private, said to be
complementary rather than competitive. Patients may
choose whether to attend primary or secondary, public or
private care. The majority of Moroccans in employment
pay for health insurance, which covers most, but not all,
of health expenses within the public and private sector.
This report summarizes the clinical characteristics of a
series of the first 186 patients reported to be admitted to
our center due to influenza A (H1N1) virus infection in
Morocco, with special interest in those developing severe
respiratory failure.
Methods
Study design and setting
We retrospectively studied all patients with confirmed
influenza A (H1N1) admitted between June and Decem-
ber 2009, to 3 departments that were reference centers
for the care of patients with influenza A (Medical emer-
gency department, paediatric department of infectious
diseases and gynaecology-obstetric department) and 4
intensive care units (ICUs) (Medical ICU, surgical ICU,
paediatric ICU, and gynaecology-obstetric ICU) in Ibn
Sina university hospital of Rabat, Morocco. Data
abstracted for this study were obtained from a voluntary
registry institute by all departments that were reference
centers after the first known (H1N1) influenza A cases.
Data collection
Data were reported by attending physicians reviewing
medical charts, radiologic and laboratory records. Inclu-
sion criteria consisted of febrile (≥38°C) acute illness,
respiratory symptoms consistent with cough, sore throat,
nasal congestion, myalgia, acute respiratory failure
requiring ICU admission, a history of travel to a country
where infection had been reported in the previous 7 days
or an epidemiologic link to a person with confirmed or
suspected infection in the previous 7 days plus microbio-
logic confirmation of novel influenza A (H1N1) virus.
Persons suspected of being infected and persons identi-
fied as close contacts were quarantined for 5 days, during
which time pharyngeal or nasopharyngeal swabs were
collected for detection of the virus by means of real-time
reverse-transcriptase-polymerase-chain-reaction (RT-
PCR). The average time between obtaining the samples
and testing was 2 hours. A confirmed case was defined
by a positive result of a RT-PCR assay performed at a
reference laboratory in Ibn Sina Hospital. Only con-
firmed cases were included in the current study. Person
with confirmed cases of infection were admitted to differ-
ent departments, where they could be quarantined. The
ICU admission criteria and treatments decisions for all
patients including determination of the need for intuba-
tion and type of antibiotic and antiviral therapy adminis-
tered were not standardized and were made by the
attending physicians. We defined critically ill patients as
those admitted to an adult or paediatric intensive care
unit, requiring mechanical ventilation, or receiving intra-
venous infusion of inotropic or vasopressor medication
during the hospitalization. Patients were followed until
discharge with symptoms and signs recorded daily. The
details of all investigations and treatments were recorded.
The criteria for discharge were two readings of normal
body temperature taken on 2 consecutive days and the
absence of respiratory symptoms. Patient’s confidentiality
was maintained and this study was approved by the local
ethics committee. The following informations were
recorded: demographic data, country of origin of the con-
tagion, symptoms, comorbidities , time off illness onset,
chest radiologic, laboratory and microbiologic findings,
ICU admission, mechanical ventilation requirement,
need for vasopressor drugs, antiviral treatment, adverse
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length of stay in the ICU, and the hospital mortality.
Statistical analysis
Data analysis was conducted using SPSS 13.0 software
(Chicago, IL, USA). Data represented as the mean ±
standard deviation for variable with a normal distribu-
tion, and as the median with interquartile range (IQR)
for variable with skewed distribution. For categorical
variables, the percentages of patients in each category
were calculated. Clinical, biological and radiologic char-
acteristics were compared between subgroups of patient
with and those without ICU admission. Differences
between subgroups were assessed using the Chi-squared
test and Fisher’s exact test for categorical variables and
the Student’s T-test or Mann-Whitney test for continu-
ous variables. A P value of 0.05 or less was considered
to be statistically significant.
Results
Demographic and clinical characteristics of the patients
Three departments located in 3 hospitals were involved in
the health response. The first case of confirmed imported
infection in our center was identified on June 15, 2009;
and the first secondary case of confirmed infection (in a
patient with known exposure to a person with imported
infection) was identified on July 8. By December 2009, a
total of 872 close contacts and suspect cases had been
tested for 2009 pandemic influenza A during quarantine,
test results were positive for 186 persons (21.3%). We ana-
lysed the first 186 cases with confirmed cases of infection
who were hospitalized. Forty patients had travelled to
infected region (table 1) (21.5%). The median duration of
symptoms before the hospital admission was 3 days (IQR:
2-5). Fever (91.5%) and cough (92.5%) were more common
in our patients. Of all patients, 50.5% had underlying med-
ical conditions. Asthma was more common in our patients
(24%). Demographic details, underlying medical conditions
and symptoms are listed in table 1. Table 2 showed char-
acteristics of ICU patients with 2009 pandemic influenza
A( H 1 N 1 )v i r u s .
Laboratory and radiographic findings
Table 3 showed laboratory and radiographic findings on
admission. We had 20 requirements for ICU care
(10.7%), and 10 requirements for mechanical ventilation
(5.3%). The results of serial virologic testing of samples
from pharyngeal or nasopharyngeal swabs with the use
of RT-PCR assay were available for all our patients.
Abnormalities in chest radiography were detected in 49
cases on admission or after hospitalization. The most
common features of these abnormalities appeared as
ground-glass opacities. Leukocytosis was found in 50.9%.
Clinical outcomes
96.5% of our patients were discharged home after a hos-
pital length of stay of 5 days (IQR: 4- 5). Treatment
with Oseltamivir was administered in a total of 184
patients within 48 hours after the onset of illness.
Twenty patients required ICU care and 10 required
mechanical ventilation. The following were risk factors
Table 1 Characteristics, underling medical conditions and
symptoms of 186 patients infected with 2009 pandemic
influenza A (H1N1) virus in Morocco
Characteristics Values
Male gender, n (%) 106 (57)
Age (yrs)
Mean ± SD 17.6 ± 14.8
Range 0.08-57
Age group, n (%)
<5 yrs 53 (28.6)
5-14 yrs 37 (20)
15-30 yrs 55 (29.2)
31-50 yrs 38 (20.5)
>51 yrs 3 (1.7)
Coexisting conditions, n (%)
Asthma 48 (24)
Pregnancy 15 (7.5)
Heart disease 13 (6.5)
Haematologic disease 10 (5)
Chronic nephritis 4 (2)
Diabetes 2 (1)
Obesity 2 (1)
Recent travel to infected region, n (%) 40 (21.5)
None 146 (78.5)
Spain 9 (22.5)
France 8 (20)
Canada/USA 7 (17.5)
United Kingdom 4 (10)
Italy 3 (7.5)
Others 9 (22.5)
Duration of symptoms (days)
Median (IQR) 3 (2-5)
Symptoms
Elevated temperature (>38°C) 170 (91.5)
Cough 172 (92.5)
Sore throat 52 (28)
Nasal congestion 116 (62.4)
Myalgia, arthralgia 78 (41.9)
Diarrhea 26 (14)
Nausea, vomiting 30 (16.1)
Headache 56 (30.1)
Hospital length of stay (days)
Median (IQR) 5 (4-5)
IQR, interquartile range; SD, standard deviation; yrs, years; USA, United States
of America.
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duration of symptoms (p = 0.07), asthma (p = 0.01),
obesity (P < 0.001), abnormalities of chest radiography
(P < 0.001), leukocytosis (p = 0.005), and higher C-reac-
tive protein (CRP) (P < 0.001). The hospital mortality
was 3.5% in our study. The mortality among ICU
patients was 30%.
Discussion
We describe a cohort of 186 patients identified in Ibn Sina
university hospital who were hospitalized for 2009 pan-
demic influenza A (H1N1) virus infection between June
and December 2009. The decision to undertake stringent
quarantine and isolation measures regarding these patients
was based on the unknown biologic action of the virus and
the absence of effective vaccination. Several studies sug-
gested an incubation period of 1 to 7 days [6,9]. In our
study, we couldn’t provide the opportunity to investigate
the incubation period without an exact date of onset of ill-
ness. To date, it has been difficult to define the true incu-
bation period of the virus [6,9,12,13]. As compared with
patients in United States [6], Japan [14], and other coun-
tries, the fever was the main symptom (94%), the same
result was found in our study (91.5%). The incidence of
nausea, vomiting and diarrhea was much lower than pre-
viously reported. Both leukocytosis and leukopenia were
found in our cohort as well as other studies [15]. As com-
pared with patients in China [9], fewer patients in our
cohort presented leukopenia (white-cell count, <4000 per
cubic millimetre) (3.9% vs 21.4%). These transient altera-
tions in the numbers of peripheral-blood leukocytes are
similar to those seen in cases of seasonal influenza. Fas-
Fas ligand signalling, which induces apoptosis, plays a
major role in the mechanisms regulating the leukocyte
population [16]. Hypokaliemia was documented in 23% of
our patients. Hypokaliemia was found in 25.4% in China
[9]. The Excessive loss by the gastrointestinal tract (diar-
rhea, and vomiting), appear to be the most obvious reason
that potassium levels are low. However, nausea and vomit-
ing can be a cause or a consequence of hypokalemia. As
compared with patients in United State [6] and china [9],
abnormalities on chest radiography were more common
in our cohort (26.3% vs 5.1% in china, 7.1 in USA). Twenty
patients had severe pneumonia requiring ICU care. Our
analysis of critically ill patients with 2009 influenza A
(H1N1) reveals that this disease affected an older patients
group. Other study revealed that H1N1 infection affected
young patients [17]. There was a relatively long period of
illness prior to presentation to the hospital among criti-
cally ill patients. The median time between the onset of
symptoms and ICU admission was 2 (2-4) vs 4 (2-7) in
ward. Late management of the disease may increase the
severity of H1N1 infection, as it is suggested by other stu-
dies [18].
Asthma and obesity were the most common comorbid
conditions in critically ill patients. Obesity and respira-
tory diseases were more prevalent in others studies
especially in critically ill patients with H1N1 infection
[17]. A better understanding of these factors, which
were common, or those that suggest a higher risk of
ICU admission may provide health care professionals an
earlier opportunity to identify and treat high risk groups.
We found that certain baseline characteristics of criti-
cally ill patients with 2009 influenza A (H1N1) may be
associated with increased ICU admission, including ele-
vated CRP, leukocytosis and more abnormalities in
Table 2 Characteristics of ICU patients infected with 2009
pandemic influenza A (H1N1) virus
Characteristics Values
Age, years
Mean ± SD 25.9 ± 18.8
Range 0.25-53
Male gender, n (%) 12 (60)
Asthma, n (%) 6 (22.2)
Obesity, n (%) 2 (7.4)
Pregnancy, n (%) 3 (11.1)
Length of stay, days
Median (IQR) 4 (3-6.7)
Mortality, n (%) 6 (30)
IQR, interquartile range; SD, standard deviation.
Table 3 Laboratory and radiographic findings in
admission
Variables Values
Abnormalities on chest radiograph, n/total n (%) 49/186 (26.3)
Opacity 1/4 quadrants 24/49 (48.9)
Opacity 2/4 quadrants 19/49 (37.7)
Opacity 3/4 quadrants 4/49 (8.1)
Opacity 4/4 quadrants 2/49 (4)
Leukocyte count
Median (IQR) (per mm3) 14600 (5400-
16100)
<4000/mm
3, n/total n (%) 4/102 (3.9)
>10000/mm
3, n/total n (%) 52/102 (50.9)
Platelet count,
Mean ± SD (per mm3) 221241 ± 169344
Potassium
Median (IQR) (meq/liter) 4.9 (3.6-5.1)
<3.5 meq/liter, n/total n (%) 14/61 (23)
Sodium, mean ± SD (meq/liter) 136 ± 5.2
C-reactive protein >10 mg/liter, n/total n (%) 55/72 (76.3)
Creatinine, median (IQR) (mg/dl) 8.9 (7.4-11.3)
Aspartate aminotransferase >40 UI/liter, n/total
n=(%)
10/30 (33.3)
Alanine aminotransferase >40 UI/liter, n/total n=
(%)
10/30 (33.3)
IQR, interquartile range; SD, standard deviation.
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lung injury which may explain these abnormalities in
laboratory and radiographic findings. All patients had an
influenza-like illness at presentation. None of the ICU
patients received Oseltamivir before admission. Accord-
ing to the WHO guidelines on the pharmacologic man-
agement of influenza virus, patients who are at risk for
pneumonia should be treated with Oseltamivir or Zana-
mivir as soon as symptoms develop, if possible [19]. At
present, however, the quality of the evidence supporting
such recommendations is low.
Limitations
Our study has some limitations. First, patients who
became infected in their community and did not go to
the hospital were not included in our study. Second, the
cases of infection in our patients are not clinically com-
parable with those in hospitalized patients in other
countries because of differences in hospitalization prac-
tices. Finally, our data do not reflect the entire country
but were collected in one university hospital at a repre-
sentative city of Morocco.
Conclusion
Close observation of patients infected with the 2009
pandemic influenza A (H1N1) virus infection provided
us with several information. The influenza A (H1N1)
virus infection affected young people particularly, with
comorbid respiratory disorders. Risk factors with ICU
admission were older age, long duration of symptoms,
asthma, obesity, abnormalities of chest radiography, leu-
kocytosis and higher CRP. Clinicians should be aware of
complications of influenza A (H1N1) virus infection,
particularly in patients with risk factors.
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